These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 23232184

  • 1. The untapped potential of Gallium 68-PET: the next wave of ⁶⁸Ga-agents.
    Smith DL, Breeman WA, Sims-Mourtada J.
    Appl Radiat Isot; 2013 Jun; 76():14-23. PubMed ID: 23232184
    [Abstract] [Full Text] [Related]

  • 2. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
    Breeman WA, de Blois E, Sze Chan H, Konijnenberg M, Kwekkeboom DJ, Krenning EP.
    Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
    [Abstract] [Full Text] [Related]

  • 3. Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.
    Kulkarni HR, Baum RP.
    PET Clin; 2014 Jan; 9(1):83-90. PubMed ID: 25029937
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.
    Henze M, Schuhmacher J, Dimitrakopoulou-Strauss A, Strauss LG, Mäcke HR, Eisenhut M, Haberkorn U.
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):466. PubMed ID: 14730407
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapy.
    Kulkarni HR, Baum RP.
    PET Clin; 2014 Jan; 9(1):91-7. PubMed ID: 25029938
    [Abstract] [Full Text] [Related]

  • 12. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement.
    Sako T, Hasegawa K, Nishimura M, Kanayama Y, Wada Y, Hayashinaka E, Cui Y, Kataoka Y, Senda M, Watanabe Y.
    Biochem Biophys Res Commun; 2013 Dec 06; 442(1-2):79-84. PubMed ID: 24220338
    [Abstract] [Full Text] [Related]

  • 13. Gallium-labelled peptides for imaging of inflammation.
    Roivainen A, Jalkanen S, Nanni C.
    Eur J Nucl Med Mol Imaging; 2012 Feb 06; 39 Suppl 1():S68-77. PubMed ID: 22388620
    [Abstract] [Full Text] [Related]

  • 14. Gallium-68 in Medical Imaging.
    Martiniova L, Palatis L, Etchebehere E, Ravizzini G.
    Curr Radiopharm; 2016 Feb 06; 9(3):187-207. PubMed ID: 27804868
    [Abstract] [Full Text] [Related]

  • 15. Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.
    Ito T, Jensen RT.
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb 06; 24(1):15-24. PubMed ID: 27875420
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. What will be required to bring ⁶⁸Ga-labelled peptides into routine clinical use?
    Ballinger JR, Solanki KK.
    Nucl Med Commun; 2011 Dec 06; 32(12):1109-12. PubMed ID: 21934542
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.